Aspen Pharmacare Holdings Company Description
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia.
It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers injectables for therapeutic areas, such as anaesthetics, anticoagulants, antithrombotic agents, analgesics, and hormone replacement medicines under the Arixtra, Diprivan, Fraxiparine, Marcaine, Sustanon, and Xylocaine brands; over-the-counter medicines under the Emla, Maltofer, Ovestin, Solpadeine, and Xylocaine brands; and prescription products for anti-inflammatories, immunosuppressants, hypothyroidism, anti-gout, analgesics, and corticosteroids under the Eltroxin, Imuran, Lipitor, Lyrica, and Zyloric brands.
It also manufactures active pharmaceutical ingredients, finished dose forms, and heparins, as well as steriles, oral solid doses, liquids, semi-solids, and biologicals.
The company exports its products. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.

Country | South Africa |
Founded | 1850 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 9,350 |
CEO | Stephen Saad |
Contact Details
Address: Aspen Place Durban South Africa | |
Phone | 27 31 580 8600 |
Website | aspenpharma.com |
Stock Details
Ticker Symbol | APN |
Exchange | Johannesburg Stock Exchange |
Fiscal Year | July - June |
Reporting Currency | ZAR |
ISIN Number | ZAE000066692 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Samer Kassem | Chief Executive Officer of Aspen Global Incorporated |
Trevor Julian Ziman | Regional Chief Executive Officer of Asia Pacific |
Stephen Bradley Saad BCom, CA(SA) | Group Chief Executive Officer and Executive Director |
Sean M. Capazorio | Group Chief Financial Officer and Executive Director |
Lorraine Hill | Group Chief Operations Officer |
Michael Guy Attridge B.Com., CA(SA) | Group Chief Advisor |
Reginald Haman Grad. Dip., MBA, ND, NHD, PGDBA | Group Chief Corporate Officer and Executive Director |
Zizipho Mmango | Group Chief Strategic Development Officer |
Sibongakonke Nkosi | Investor Relations Manager |
Raeesa Khan | Group Company Secretary and Chief of Staff |